MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Revenue
$15,232K
Net Income
-$426K
Net Profit Margin
-2.80%
Unit: Thousand (K) dollars
Revenue Breakdown
Pharmacology Services
Translational Oncology Solutions...
Product And Service Other
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-07-31
2026-04-30
2026-01-31
2025-10-31
Oncology revenue
15,232
13,836
16,559
15,035
Cost of oncology revenue
7,534
6,809
8,834
7,262
Research and development
2,344
2,115
2,271
2,616
Sales and marketing
3,090
2,799
2,666
1,998
General and administrative
2,673
2,633
2,975
2,974
Loss on disposal of equipment
0
-2
-89
0
Total costs and operating expenses
15,641
14,358
16,835
14,850
Loss from operations
-409
-522
-276
185
Other income (expense), net
-6
27
39
70
Loss before provision for income taxes
-415
-495
-237
255
Provision for income taxes
11
172
42
18
Net income (loss)
-
-728
-
237
Less net loss attributable to noncontrolling interest
-
-
-
-31
Net income (loss) attributable to company's common shares
-426
-
-279
268
Basic EPS
-0.03
-0.053
-0.02
0.02
Diluted EPS
-
-0.055
-0.02
0.02
Basic Average Shares
13,897,535
13,862,416
13,886,797
13,791,913
Diluted Average Shares
-
13,196,492
13,886,797
14,457,837
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
CSBR Income Statement Sankey Diagram
Sankey diagram visualizing CSBR income statement for the period
Net income (loss)
attributable to company's...
-$426K
(2.29%↑ Y/Y)
Loss before
provision for income taxes
-$415K
(8.19%↑ Y/Y)
Provision for income taxes
$11K
(-21.43%↓ Y/Y)
Pharmacology Services
$14,156K
Translational Oncology
Solutions TOSLicense...
$893K
(187.14%↑ Y/Y)
Product And Service
Other
$183K
(-59.69%↓ Y/Y)
Loss from operations
-$409K
(22.39%↑ Y/Y)
Other income
(expense), net
-$6K
(-108.00%↓ Y/Y)
Oncology revenue
$15,232K
(8.84%↑ Y/Y)
Total costs and
operating expenses
$15,641K
(7.71%↑ Y/Y)
Cost of oncology
revenue
$7,534K
(-5.77%↓ Y/Y)
Sales and marketing
$3,090K
(66.58%↑ Y/Y)
General and
administrative
$2,673K
(4.01%↑ Y/Y)
Research and development
$2,344K
(12.58%↑ Y/Y)
Buy us a coffee
CHAMPIONS ONCOLOGY, INC. (CSBR)
CHAMPIONS ONCOLOGY, INC. (CSBR)